Bortenat Injection, Composition: Bortezomib

₹ 290.00 Per Pack

Min. Order: 1 Piece

Bortenat Injection, containing Bortezomib, is crucial in treating multiple myeloma and mantle cell lymphoma by inhibiting proteins essential for cancer cell growth. Administered intravenously or subcutaneously, it disrupts cancer cell cycles, prompting their death. This treatment is typically considered after other options have been exhausted. Common side effects like nausea, diarrhea, fatigue, and nerve damage may occur but are manageable with medical oversight. Monitoring during treatment is crucial to gauge its effectiveness and address any issues promptly. Always adhere to healthcare provider guidance and report any concerning symptoms to ensure optimal care.